K‑001
Non‑small cell lung cancer
Phase 3Active
Key Facts
About Kalbe
Indonesia's top integrated healthcare group driving growth through innovative biologics and broad consumer health portfolio.
View full company profileTherapeutic Areas
Other Non‑small cell lung cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Virtual PD‑L1 IHC | ViewsML Technologies | Service Offering |